comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 04:13:56 - browse：28388

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

focus

WSS

Feng Zhang, Grail founder join forces on new gene editing startup

How a scoliosis diagnosis changed the life of one young dancer

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Health and fitness trackers are measuring the wrong things

GSK Flovent asthma inhalers replaced by authorized generics

focus

comprehensive

hotspot

Hollywood unions extend contract negotiations for actors

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Psychedelics group wrestles with new pharma identity

Generative AI mines health records to identify patients’ social needs

Hollywood unions extend contract negotiations for actors

Caregivers of transplant patients call for more support, training

Dobbs anniversary: the lost opportunity of abortion as health care

How I ended up pumping milk in a bathroom stall at JPM 2024

Activists slam private health insurers over coverage restrictions

Why psychiatrists like me stop taking insurance

focus

New menopause drug shows promise in relief for hot flashes

Chronically ill young patients struggle to find fertility info

Heart disease and mental health: A look at cardiac psychology

Federal weight loss drug coverage is 30 years out of date

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Antibiotic resistance and the global rise in human conflict

focus

knowledge

Wikipedia

focus